![]() |
|
|
Forward to a colleague |
||
Access Full Stories It's a liquid. No it's a solid.........No it's, 'foam-on-a-spoon'... Read Merck heads to Ireland for new €200m site Merck has settled on a site in south east Ireland for a new vaccines and biologics facility, investing €200m ($280m) in its third facility on the island... Read Chromatide wins GRAND grant for enzyme-catalysis development Chromatide has been awarded a grant to help it develop an enzyme immobilisation method using its unique polymer systems that should enable them to be used in flow-chemistry systems... Read AstraZeneca finds buyer for German plant Reports emerged in the German press yesterday claiming that AstraZeneca has found a buyer for its Plankstadt manufacturing facility... Read PolyTherics gets funding for antibody fragments PolyTherics has been boosted with £350,000 ($723,135) in funding to explore the development and production of long-lasting therapeutic antibody fragments... Read |
|||||||||||||||||||
All News Headlines for: November | October | September |
|||||||||||||||||||
![]() SOF'BAG: the airless package to dispense creams, lotions and gels Rexam Pharma presents a total packaging system for transdermal and topical application. The SOF'BAG is easy-to-use for patients while keeping filling simple and logistics easy for drug manufacturers... Click Here | |||||||||||||||||||
Private equity firm puts crores into Indian CRO GVK Bio has reinforced its claim to be India's top CRO with $25m of private investment that will be used to expand its drug discovery services and push further into preclinical and clinical development... Read Xenome and Amylin team up to poison metabolic diseases Xenome, which specialises in extracting therapeutic peptides from the venom of poisonous animals has penned a deal with Amylin Pharmaceuticals to find drugs that tackle metabolic diseases such as diabetes and obesity... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving ChemDiv, SRI International, ShangPharma, Ranbaxy and Xceleron... Read Targeted Genetics restarts trial after death The US Food and Drug Administration has allowed Targeted Genetics to restart testing its arthritis gene therapy after deciding the drug wasn't at fault when one person died in the original clinical trial... Read
|
|||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||